C, B., P, A., F, G., É, R., K, S., F, G., . . . P, B. (2023). Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI): Protocol for a phase 2a randomized controlled trial. Frontiers in medicine, 10, 1198173. https://doi.org/10.3389/fmed.2023.1198173
Chicago Style (17th ed.) CitationC, Braun, Azzano P, Gingras-Lessard F, Roy É, Samaan K, Graham F, Paradis L, Des Roches A, and Bégin P. "Abatacept to Induce Remission of Peanut Allergy During Oral Immunotherapy (ATARI): Protocol for a Phase 2a Randomized Controlled Trial." Frontiers in Medicine 10 (2023): 1198173. https://doi.org/10.3389/fmed.2023.1198173.
MLA (9th ed.) CitationC, Braun, et al. "Abatacept to Induce Remission of Peanut Allergy During Oral Immunotherapy (ATARI): Protocol for a Phase 2a Randomized Controlled Trial." Frontiers in Medicine, vol. 10, 2023, p. 1198173, https://doi.org/10.3389/fmed.2023.1198173.